Ares (ARES) insider files Form 144 for 533,796-share sale valued at $100.2M
Rhea-AI Filing Summary
Ares Management Corporation (ARES) Form 144 notice reports a proposed sale of 533,796 common shares through Morgan Stanley Smith Barney on 08/18/2025 with an aggregate market value of $100,236,212.88. The shares were acquired as Founders Shares from the issuer on 05/02/2014. The filing also lists 10b5-1 sales by ATTICUS ENTERPRISES LLC during the past three months on 05/19/2025, 05/20/2025, 05/21/2025, and 08/15/2025 with individual gross proceeds shown. The filer certifies no undisclosed material adverse information and references Rule 10b5-1 trading plan language.
Positive
- Full regulatory disclosure of proposed sale including broker, share count, and aggregate market value
- Inclusion of 10b5-1 sales history for transparency about recent insider dispositions
- Acquisition details provided (Founders Shares acquired 05/02/2014 from the issuer)
Negative
- Large aggregate market value of proposed sale: $100,236,212.88, indicating significant insider liquidity
- Multiple recent 10b5-1 sales by ATTICUS ENTERPRISES LLC in May and August 2025 with substantial gross proceeds
Insights
TL;DR: Insider notice discloses a substantial proposed sale and recent systematic 10b5-1 transactions, providing transparency but signaling share disposition.
The filing explicitly details a proposed sale of 533,796 common shares with an aggregate market value of $100,236,212.88 to be executed through Morgan Stanley Smith Barney on 08/18/2025. It confirms the shares were acquired as founders shares on 05/02/2014. The record of multiple 10b5-1 sales by ATTICUS ENTERPRISES LLC in May and August 2025 and the certification regarding material nonpublic information are important for investors monitoring insider liquidity and planned dispositions.
TL;DR: Filing shows standard Rule 144 notice and 10b5-1 activity; it is a routine disclosure of insider share sales.
The notice follows Rule 144 requirements, naming broker, share amounts, and acquisition details. It documents founders shares acquired from the issuer on 05/02/2014 and references prior 10b5-1 executions with specific dates and gross proceeds. The signature representation that no material undisclosed information exists is included, consistent with compliance norms for planned insider sales.
FAQ
What is the aggregate market value of the proposed sale on Form 144?
Which broker is handling the proposed sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.